These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22188323)

  • 1. Total synthesis of [Ψ[C(═S)NH]Tpg4]vancomycin aglycon, [Ψ[C(═NH)NH]Tpg4]vancomycin aglycon, and related key compounds: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.
    Xie J; Okano A; Pierce JG; James RC; Stamm S; Crane CM; Boger DL
    J Am Chem Soc; 2012 Jan; 134(2):1284-97. PubMed ID: 22188323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total synthesis and evaluation of [Psi[CH2NH]Tpg4]vancomycin aglycon: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.
    Crowley BM; Boger DL
    J Am Chem Soc; 2006 Mar; 128(9):2885-92. PubMed ID: 16506767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total syntheses and initial evaluation of [Ψ[C(═S)NH]Tpg⁴]vancomycin, [Ψ[C(═NH)NH]Tpg⁴]vancomycin, [Ψ[CH₂NH]Tpg⁴]vancomycin, and their (4-chlorobiphenyl)methyl derivatives: synergistic binding pocket and peripheral modifications for the glycopeptide antibiotics.
    Okano A; Nakayama A; Wu K; Lindsey EA; Schammel AW; Feng Y; Collins KC; Boger DL
    J Am Chem Soc; 2015 Mar; 137(10):3693-704. PubMed ID: 25750995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A redesigned vancomycin engineered for dual D-Ala-D-ala And D-Ala-D-Lac binding exhibits potent antimicrobial activity against vancomycin-resistant bacteria.
    Xie J; Pierce JG; James RC; Okano A; Boger DL
    J Am Chem Soc; 2011 Sep; 133(35):13946-9. PubMed ID: 21823662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total synthesis of [Ψ[C(═NH)NH]Tpg(4)]vancomycin and its (4-chlorobiphenyl)methyl derivative: impact of peripheral modifications on vancomycin analogues redesigned for dual D-Ala-D-Ala and D-Ala-D-Lac binding.
    Okano A; Nakayama A; Schammel AW; Boger DL
    J Am Chem Soc; 2014 Oct; 136(39):13522-5. PubMed ID: 25211770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of selected key methyl ether derivatives of vancomycin aglycon.
    Crane CM; Pierce JG; Leung SS; Tirado-Rives J; Jorgensen WL; Boger DL
    J Med Chem; 2010 Oct; 53(19):7229-35. PubMed ID: 20853900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silver(I)-promoted conversion of thioamides to amidines: divergent synthesis of a key series of vancomycin aglycon residue 4 amidines that clarify binding behavior to model ligands.
    Okano A; James RC; Pierce JG; Xie J; Boger DL
    J Am Chem Soc; 2012 May; 134(21):8790-3. PubMed ID: 22568755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maxamycins: Durable Antibiotics Derived by Rational Redesign of Vancomycin.
    Wu ZC; Boger DL
    Acc Chem Res; 2020 Nov; 53(11):2587-2599. PubMed ID: 33138354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent Total Synthesis and Characterization of Maxamycins.
    Moore MJ; Qin P; Keith DJ; Wu ZC; Jung S; Chatterjee S; Tan C; Qu S; Cai Y; Stanfield RL; Boger DL
    J Am Chem Soc; 2023 Jun; 145(23):12837-12852. PubMed ID: 37278486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of vancomycin aglycon analogues that bear modifications in the N-terminal D-leucyl amino acid.
    Crane CM; Boger DL
    J Med Chem; 2009 Mar; 52(5):1471-6. PubMed ID: 19209892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral modifications of [Ψ[CH
    Okano A; Isley NA; Boger DL
    Proc Natl Acad Sci U S A; 2017 Jun; 114(26):E5052-E5061. PubMed ID: 28559345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycopeptide antibiotic analogs efficient against vancomycin-resistant bacteria: a patent evaluation (WO2013022763).
    Olsufyeva EN; Preobrazhenskaya MN
    Expert Opin Ther Pat; 2013 Dec; 23(12):1625-34. PubMed ID: 23972226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of the vancomycin CDE ring system.
    Boger DL; Beresis RT; Loiseleur O; Wu JH; Castle SL
    Bioorg Med Chem Lett; 1998 Apr; 8(7):721-4. PubMed ID: 9871529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-Generation Total Synthesis of Vancomycin.
    Moore MJ; Qu S; Tan C; Cai Y; Mogi Y; Jamin Keith D; Boger DL
    J Am Chem Soc; 2020 Sep; 142(37):16039-16050. PubMed ID: 32885969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the role of the vancomycin e-ring aryl chloride: selective divergent synthesis and evaluation of alternatively substituted E-ring analogues.
    Pinchman JR; Boger DL
    J Med Chem; 2013 May; 56(10):4116-24. PubMed ID: 23617725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First and second generation total synthesis of the teicoplanin aglycon.
    Boger DL; Kim SH; Mori Y; Weng JH; Rogel O; Castle SL; McAtee JJ
    J Am Chem Soc; 2001 Mar; 123(9):1862-71. PubMed ID: 11456806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total synthesis of the ristocetin aglycon.
    Crowley BM; Mori Y; McComas CC; Tang D; Boger DL
    J Am Chem Soc; 2004 Apr; 126(13):4310-7. PubMed ID: 15053621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants for differential effects on D-Ala-D-lactate vs D-Ala-D-Ala formation by the VanA ligase from vancomycin-resistant enterococci.
    Lessard IA; Healy VL; Park IS; Walsh CT
    Biochemistry; 1999 Oct; 38(42):14006-22. PubMed ID: 10529248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of vancomycin and vancomycin aglycon analogues that bear modifications in the residue 3 asparagine.
    McAtee JJ; Castle SL; Jin Q; Boger DL
    Bioorg Med Chem Lett; 2002 May; 12(9):1319-22. PubMed ID: 11965380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved preparative enzymatic glycosylation of vancomycin aglycon and analogues.
    Moore MJ; Qin P; Keith DJ; Boger DL
    Tetrahedron; 2023 Jan; 131():. PubMed ID: 36776940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.